Arabic Arabic English English French French German German
dark

Hemogenyx Pharmaceuticals and Selexis SA Will Advance Hemogenyx’s Acute Myeloid Leukemia (AML) CDX Bispecific Antibody to Human Trials

Hemogenyx Pharmaceuticals will leverage Selexis’ SUREtechnology Platform™ of protein expression technologies and modular workflows. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Gracell Biotechnologies Unveils Innovation Center in U.S.

Next Post

AlzeCure Holds a Digital Capital Markets Day on 18 January

Related Posts
Total
0
Share